Jonathan Rosen
7Patents
3h-index
10Co-inventors
54Inventor score
Filing activity: Jun 13, 1988 → Jul 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4943628A | HIV peptide-inducted T cell stimulation | Chemistry; Metallurgy | 51 | Expired |
| US11413309B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | Emerging Cross-Sectional Technologies | 4 | Active |
| US11096964B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | Emerging Cross-Sectional Technologies | 4 | Active |
| US11932870B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | Emerging Cross-Sectional Technologies | 2 | Active |
| US12036241B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | Emerging Cross-Sectional Technologies | 0 | Active |
| US12281329B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | Emerging Cross-Sectional Technologies | 0 | Active |
| US12419870B2 | Compositions and methods for immune cell modulation in adoptive immunotherapies | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.